About
GeneCentric develops software and liquid biopsy technologies that extract gene expression data from circulating tumor DNA using fragmentomics and NGS workflows to enhance cancer genomic profiling and support precision oncology.
Explore GeneCentric's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.